SEARCH

SEARCH BY CITATION

References

  • 1
    Vincent A, Awada L, Brown I et al. Review of Influenza A Virus in Swine Worldwide: a Call for Increased Surveillance and Research. Zoonoses Public Health 2013; doi: 10.1111/zph.12049.
  • 2
    Zhou NN, Senne DA, Landgraf JS et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 1999; 73:88518856.
  • 3
    Webby RJ, Swenson SL, Krauss SL et al. Evolution of swine H3N2 influenza viruses in the United States. J Virol 2000; 74:82438251.
  • 4
    Hause BM, Oleson TA, Bey RF, Stine DL, Simonson RR. Antigenic categorization of contemporary H3N2 Swine influenza virus isolates using a high-throughput serum neutralization assay. J Vet Diagn Invest 2010; 22:352359.
  • 5
    Leuwerke B, Kitikoon P, Evans R, Thacker E. Comparison of three serological assays to determine the cross-reactivity of antibodies from eight genetically diverse U.S. swine influenza viruses. J Vet Diagn Invest 2008; 20:426432.
  • 6
    Richt JA, Lager KM, Janke BH et al. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 Swine influenza viruses cocirculating in the United States. J Clin Microbiol 2003; 41:31983205.
  • 7
    Olsen CW, Karasin AI, Carman S et al. Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 2006; 12:11321135.
  • 8
    Lorusso A, Vincent AL, Gramer MR, Lager KM, Ciacci-Zanella JR. Contemporary epidemiology of North American lineage triple reassortant influenza A viruses in pigs. Curr Top Microbiol Immunol 2013; 370:11332.
  • 9
    Shu B, Garten R, Emery S et al. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990–2010. Virology 2012; 422:151160.
  • 10
    Kitikoon P, Nelson MI, Killian ML et al. Genotype patterns of contemporary reassorted H3N2 virus in US swine. J Gen Virol 2013; 94:12361241.
  • 11
    CDC. Influenza A (H3N2) variant virus-related hospitalizations — Ohio, 2012. MMWR Morb Mortal Wkly Rep 2012; 61(39):802.
  • 12
    Nelson MI, Vincent AL, Kitikoon P, Holmes EC, Gramer MR. Evolution of novel reassortant A/H3N2 influenza viruses in North American swine and humans, 2009–2011. J Virol 2012; 86:88728878.
  • 13
    Houser KV, Katz JM, Tumpey TM. Seasonal trivalent inactivated influenza vaccine does not protect against newly emerging variants of influenza A (H3N2v) virus in ferrets. J Virol 2013; 87:12611263.
  • 14
    Skowronski DM, De Serres G, Janjua NZ et al. Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro Surveill 2012; 17:185261.
  • 15
    Van Reeth K, Ma W. Swine influenza virus vaccines: to change or not to change-that's the question. Curr Top Microbiol Immunol 2012; 370:173200.
  • 16
    Gasparini R, Amicizia D, Lai PL, Panatto D. Live attenuated influenza vaccine–a review. J Prev Med Hyg 2011; 52:95101.
  • 17
    Markowska-Daniel I, Pomorska-Mol M, Pejsak Z. The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs. Vet Immunol Immunopathol 2011; 142:8186.
  • 18
    Beaudoin A, Johnson S, Davies P, Bender J, Gramer M. Characterization of influenza a outbreaks in Minnesota swine herds and measures taken to reduce the risk of zoonotic transmission. Zoonoses Public Health 2012; 59:96106.
  • 19
    Allerson M, Deen J, Detmer SE et al. The impact of maternally derived immunity on influenza A virus transmission in neonatal pig populations. Vaccine 2013; 31:500505.
  • 20
    Kitikoon P, Nilubol D, Erickson BJ et al. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination. Vet Immunol Immunopathol 2006; 112:117128.
  • 21
    Vincent AL, Ma W, Lager KM et al. Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease. J Virol 2012; 86:1059710605.
  • 22
    World Health Organization. 2002. Available at WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf (Accessed June 2012).
  • 23
    Ciacci-Zanella JR, Vincent AL, Prickett JR, Zimmerman SM, Zimmerman JJ. Detection of anti-influenza A nucleoprotein antibodies in pigs using a commercial influenza epitope-blocking enzyme-linked immunosorbent assay developed for avian species. J Vet Diagn Invest 2010; 22:39.
  • 24
    Tang Y, Lee CW, Zhang Y et al. Isolation and characterization of H3N2 influenza A virus from turkeys. Avian Dis 2005; 49:207213.
  • 25
    Pena L, Vincent AL, Ye J et al. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol 2011; 85:456469.
  • 26
    Halbur PG, Paul PS, Frey ML et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 1995; 32:648660.
  • 27
    Gauger PC, Vincent AL, Loving CL et al. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus. Vet Pathol 2012; 49:900912.
  • 28
    Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938; 27:493497.
  • 29
    Cai Z, Zhang T, Wan XF. A computational framework for influenza antigenic cartography. PLoS Comput Biol 2010; 6:e1000949.
  • 30
    Loeffen WLA, Heinen PP, Bianchi ATJ, Hunneman WA, Verheijden JHM. Effect of maternally derived antibodies on the clinical signs and immune response in pigs after primary and secondary infection with an influenza H1N1 virus. Vet Immunol Immunopathol 2003; 92:2335.
  • 31
    Kitikoon P, Vincent AL, Gauger PC et al. Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010–2011. J Virol 2012; 86:68046814.
  • 32
    Kappes MA, Sandbulte MR, Platt R et al. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Vaccine 2012; 30:280288.
  • 33
    Wesley RD, Lager KM. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus. Vet Microbiol 2006; 118:6775.
  • 34
    Gorres JP, Lager KM, Kong WP et al. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Clin Vaccine Immunol 2011; 18:19871995.
  • 35
    Loving CL, Vincent AL, Pena L, Perez DR. Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs. Vaccine 2012; 30:58305838.